Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT04529499
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

Who this might be right for
Covid19
Dr. Reddy's Laboratories Limited 353
Post-approval studies (Phase 4)UnknownNCT05697055
What this trial is testing

Efficacy and Safety of Azvudine vs. Nirmatrelvir-Ritonavir in the Treatment of COVID-19 Infection

Who this might be right for
COVID-19
Shandong Provincial Hospital 410
Not applicableStudy completedNCT07072793
What this trial is testing

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Pfizer 131,005
Large-scale testing (Phase 3)Ended earlyNCT04371393
What this trial is testing

MSCs in COVID-19 ARDS

Who this might be right for
Mesenchymal Stromal CellsRemestemcel-LAcute Respiratory Distress Syndrome+1 more
Icahn School of Medicine at Mount Sinai 223
Large-scale testing (Phase 3)Study completedNCT04603729
What this trial is testing

Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease

Who this might be right for
Covid 19 Disease
Fatima Memorial Hospital 100
Early research (Phase 1)Study completedNCT05151614
What this trial is testing

Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection

Who this might be right for
COVID-19 Pandemic
University of Baghdad 160
Not applicableUnknownNCT06452069
What this trial is testing

Efficacy and Safety Study of Essential Oil-Based Preparation Administered to COVID-19 Patients

Who this might be right for
COVID-19 Respiratory InfectionCOVID-19
Biodex S.A 280
Testing effectiveness (Phase 2)Study completedNCT04453384
What this trial is testing

Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia

Who this might be right for
SARS Virus
Nantes University Hospital 416
Early research (Phase 1)Study completedNCT04766931
What this trial is testing

The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection

Who this might be right for
Covid19
Frontier Biotechnologies Inc. 88
Not applicableStudy completedNCT05343728
What this trial is testing

Thromboelastographic Methods in Deciding Therapy on Moderate to Severe COVID-19 Patients

Who this might be right for
COVID-19
Universitas Indonesia 100
Large-scale testing (Phase 3)UnknownNCT04669015
What this trial is testing

Phase 3 Inhaled Novaferon Study in Hospitalized Patients With Moderate to Severe COVID-19

Who this might be right for
Covid19
Genova Inc. 914
Large-scale testing (Phase 3)UnknownNCT04952805
What this trial is testing

Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19.

Who this might be right for
Covid19
Toscana Life Sciences Sviluppo s.r.l. 800
Testing effectiveness (Phase 2)Ended earlyNCT04582318
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19

Who this might be right for
SARS-CoV-2 Infection
NGM Biopharmaceuticals, Inc 16
Large-scale testing (Phase 3)Study completedNCT04603924
What this trial is testing

Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients

Who this might be right for
COVID-19
NeuroBo Pharmaceuticals Inc. 49
Testing effectiveness (Phase 2)Study completedNCT04900337
What this trial is testing

Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients.

Who this might be right for
Covid19
Amorphical Ltd. 66
Testing effectiveness (Phase 2)WithdrawnNCT04452097
What this trial is testing

Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS

Who this might be right for
COVID-19ARDSAcute Respiratory Distress Syndrome
Baylx Inc.
Testing effectiveness (Phase 2)UnknownNCT04674566
What this trial is testing

Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19

Who this might be right for
Covid19
Corat Therapeutics Gmbh 45
Large-scale testing (Phase 3)Study completedNCT04501783
What this trial is testing

Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
R-Pharm 168
Large-scale testing (Phase 3)UnknownNCT05675072
What this trial is testing

Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19

Who this might be right for
Mild to Moderate COVID-19
Frontier Biotechnologies Inc. 1,336
Very early researchTemporarily pausedNCT04329572
What this trial is testing

Efficacy and Safety of Hydroxychloroquine and Azithromycin for Patients With Moderate to Severe COVID-19

Who this might be right for
COVID-19
Azidus Brasil 400
Next Page